icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Sat 17 Oct 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

Drug Approvals

SFDA Approved Use

Pemigatinib monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or rearrangement that have progressed after at least prior line of systemic therapy
This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and decision of clinical benefit in a confirmatory trial(s).
 
Comments and Suggestions

Comments and Suggestions

For any inquiries or comments about the government services, please fill in the required information.

Last update date: 30/09/2026 at 07:29 AM Saudi Arabia time